Juan Pedro Auriol has been appointed as the new commercial director of the Diabetes de Novo Nordisk Spain, reporting Olga Insua, general director of the Spanish affiliate.
It will also occupy the position and be part of the management team of Spain.From its position, it will be responsible for the sales of all products in the diabetes portfolio, through the execution of the strategy and leading the effectiveness of the commercial equipment.
Given this new stage, Juan Pedro has expressed his pride in being part of a company that has been taking care of and improving the health of patients for almost 100 years;where excellent professionals have been found that are leading the change in diabetes care.
In addition, he has a degree in Biological and Biochemistry Sciences, from the Complutense University of Madrid and has a postgraduate courage in Business Administration from the Polytechnic University of Madrid.He began his professional career in the Ferring Pharmaceuticals sales team, first as a sales delegate and subsequently as regional sales manager.
At four years, he went on to occupy the position of sales director in Norgine where he remained 10 years.From 2007 to 2011, he occupied the position of manager of the Bixter Biosurgery business unit and subsequently director of the Hemophilia & AMP business unit;Vaccines in Baxter itself.
During his last stage, he has been in Baxalta (Shire), as general director and responsible for the area of hematology for Spain and Portugal.
